People
Heather Preston
Heather Preston was publicly named by Arkuda Therapeutics as Board Member. Arkuda appointed her to its board in February2022 when Pivotal bioVenture Partners co-led the USD64M SeriesB. Her current own Harness biography identifies its board-chair role, over30years in healthcare, a medical degree from Oxford and earlier biotech-investment experience; the2022 Pivotal title is historical. Arkuda affiliation is historical; continued employment or board membership after the2025 asset sale is unverified.
Roles
Harness Therapeutics
CurrentBoard Chair
Arkuda Therapeutics
CurrentBoard Member (appointed February2022; historical)